Cellmic, LLC (formerly Holomic) is a technology company dedicated to improving patient healthcare with the use of smartphones and biophotonics. Cellmic is a licensee of UCLA and collaborates closely with Professor Aydogan Ozcan and his research group at the university. Cellmic’s first commercialization success was a product line of readers for lateral flow immunoassays that is now part of NOW Diagnostics, Inc. Cellmic continues with the commercialization of other technologies in their portfolio, including microplate readers, lens-free holographic microscopes, and handheld analyzers for blood count, allergens, and mercury contamination. The company earned the Technology Pioneer 2015 award by the World Economic Forum in Davos; was a finalist for the Katerva, Nokia Sensing X-Challenge, and SPIE PRISM awards; and has won numerous government and corporate contracts.

Read more about NOW Diagnostics' acquisition of Cellmic's reader technology here!